APP下载

血清胱抑素C在慢性心力衰竭早期诊断中的临床意义

2017-07-01滕艳春潘虹

中国实用医药 2017年17期
关键词:慢性心力衰竭

滕艳春+潘虹

【摘要】 目的 分析血清胱抑素(Cys C)對慢性心力衰竭(CHF) 早期诊断的意义。方法 106例住院患者, 将患者分为对照组(35例)和病例组(71例)。对照组为既无器质性心脏病又无心力衰竭症状的患者, 病例组包括既有器质性心脏病和(或)心力衰竭症状的患者。对两组进行基线分析, 采用Logistic单因素和多因素分析, 确定CHF的独立危险因素。进行受试者工作特征曲线(ROC)分析确定Cys C作为CHF早期的评价指标的最佳界值。结果 病例组患者的Cys C水平(1.14±0.37)mg/L, 明显高于对照组患者的(0.87±0.27)mg/L, 差异有统计学意义(P<0.05)。相关性分析发现, 在单因素分析中Cys C在CHF早期诊断的OR值为17.701, 说明Cys C与CHF早期密切相关。调整相关影响因素后进行多因素Logistic回归分析, 发现Cys C无论是作为连续变量还是二分类变量, 其都是CHF早期的重要危险因素(OR值分别为7.553、9.776), 提示Cys C可能是CHF早期的独立危险因素。通过ROC曲线获得Cys C作为CHF早期诊断评价指标的最佳界点值是0.8850 mg/L, 灵敏度为77.5%, 特异度为71.4%, 结果说明此界值有较好的灵敏度和特异度。结论 Cys C是CHF的独立危险因素, 对CHF早期诊断具有重要临床意义。

【关键词】 慢性心力衰竭; 血清胱抑素C;临床诊断

DOI:10.14163/j.cnki.11-5547/r.2017.17.003

Clinical significance of serum cystatin C in early diagnosis of chronic heart failure TENG Yan-chun, PAN Hong. Shenzhen City Baoan District Fuyong Peoples Hospital, Shenzhen 518100, China

【Abstract】 Objective To analyze significance of serum cystatin C (Cys C) in early diagnosis of chronic heart failure (CHF). Methods A total of 106 hospitalized patients were randomly divided into control group (35 cases) and case group (71 cases). The control group contained patients without organic heart disease and heart failure symptoms, and the case group contained patients with organic heart disease and (or) heart failure symptoms. Both groups received baseline analysis. Univariate and multivariate Logistic analysis were applied to determine independent risk factor for CHF. Receiver operating characteristic (ROC) curve was used to analyze and determine the best cut-off value by Cys C as early evaluation index for CHF. Results The case group had obviously higher Cys C level as (1.14±0.37) mg/L than (0.87±0.27) mg/L in the control group, and their difference had statistical significance (P<0.05). Correlation analysis showed OR value by Cys C as 17.701 in univariate analysis for early diagnosis of CHF, and it showed close correlation between Cys C and early CHF. Multivariate Logistic analysis after regulation of related influencing factors showed Cys C, acting as continuous variable or binary variable, as the important risk factor for early CHF (OR value respectively as 7.553, 9.776). Cys C was suggested as the independent risk factor for early CHF. ROC curve showed that best cut-off value as 0.8850 mg/L by Cys C as early evaluation index for CHF, along with sensitivity as 77.5% and specificity as 71.4%. The cut-off value contained good sensitivity and specificity. Conclusion As the independent risk factor for CHF, Cys C shows important clinical significance for early diagnosis of CHF.

【Key words】 Chronic heart failure; Serum cystatin C; Clinical diagnosis

慢性心力衰竭(chronic heart failure, CHF)是大多数心血管疾病的最终归宿。近年来, CHF患病率逐年升高并且预后差, 早期进行合适的治疗可以改善预后。现阶段尚缺乏简单实用的实验室检测手段。理想的诊断和判断CHF严重程度的实验室标志物对于CHF患者的早期诊断与治疗非常重要。血清胱抑素C(cystain C, Cys C)是一种半胱氨酸蛋白酶抑制剂, 由122个氨基酸组成, 相对分子质量约为13300, 等电点为9.3[1]。人类所有有核细胞均可分泌Cys C, 其分泌及排泄均不受任何外来因素, 如性别、年龄、饮食等的影响[2-4]。Cys C相对分子质量低, 等电点高, 因此可被肾小球的滤过膜滤过, 在近曲小管被完全重吸收并被完全分解代谢。肾小管不分泌Cys C。肾脏是清除循环中Cys C的惟一器官。且Cys C生成速度和血液浓度稳定[5], 因此Cys C是反映早期肾小球滤过率(GFR)变化理想, 可靠的内源性标志物[6, 7]。研究表明[8-10], 高水平的Cys C与左心室肥厚以及舒张功能不全密切相关, 血清Cys C是发现无症状的心脏结构异常的有用指标。……

登录APP查看全文

猜你喜欢

慢性心力衰竭
不同剂型美托洛尔治疗慢性心力衰竭的效果评价
培哚普利、美托洛尔联合治疗慢性心力衰竭的临床分析
曲美他嗪在老年慢性心力衰竭患者中的临床应用
应用缬沙坦、卡维地洛联合治疗慢性心力衰竭35例的效果观察
慢性心力衰竭患者治疗前后血清CA125、TNF—α水平变化及其与LVEF的关系探究
探讨护理干预对慢性心力衰竭患者治疗依从性及生活质量的影响
舒心通脉组方治疗慢性心衰心肺气虚证患者的临床观察与药学监护
探讨阿托伐他汀对慢性心力衰竭患者防治作用的有效性
40例慢性心力衰竭住院患者下呼吸道感染临床分析
阿托伐他汀联合中医中药改善慢性心力衰竭预后的临床观察